The health tech startup Sugar.fit has announced that it has raised USD 11 million in Series A funding. With involvement from current investors Cure.fit, Tanglin Venture Partners, and Endiya Partners, MassMutual Ventures led the fundraising.
The new funding will be utilised to broaden Sugar.fit’s product line, establish an offline presence, and quicken diabetes management-related research and development, all of which will increase the brand’s popularity and footprint.
Madan Somasundaram, co-founder & CEO of Sugar.fit said, “We are grateful for the trust and support our investors have in us. We are more committed than ever to helping people with Type 2 and pre-diabetes manage and reverse their condition. This investment will enable us to further enhance our technology and expand our reach across India, ultimately helping more people take control of their diabetes and improve their health.”
According to the company’s statement, Sugar.fit provides a comprehensive diabetes care programme by integrating a range of devices, including fitness trackers, constant glucose tracks, and other health tests. It also makes diabetic specialists and fitness coaches easily accessible.
Anvesh Ramineni, Managing Partner at MassMutual Ventures said, “We are thrilled to lead the Series A funding round for Sugar.fit. The team’s approach to diabetes management combines hardware, software and analytics to deliver a personalized program and drive lasting behavioural change for better health outcomes. We believe in Sugar.fit will transform the health of millions while battling the increasing incidence of diabetes in India.”
Sugar.fit is a health technology firm based in Bengaluru that aims to assist users in the management and reversal of diabetes.